CIO survey reveals healthcare is lacking in THIS aspect of business
Although the healthcare field has been ahead of embracing the mobile health industry for some time now, the industry as a whole still fails to improve one key aspect: leveraging mobile to better engage customers and/or patients.
Recently, a survey of 2,300 chief information officers at various U.S. companies was released, and the results were less then positive in terms of how companies are working to better engage their customers. Over 70 percent of CIOs reported that they had some kind of mobile strategy for interacting with customers, but most of those came in at 56 percent, saying that they have both native apps and mobile-friendly websites.
The survey was conducted by Robert Half Technology, and the findings went on to demonstrates that a percentage of CIOs at healthcare companies had no mobile strategy at all, compared to others from various disciplines. A total of 36 percent of CIOS at healthcare companies reported having no strategy at all, where 60 percent of CIOs from business and retail companies said they employ both apps and mobile-friendly websites in their business ventures.
“To maintain competitive advantage, sectors such as business services and retail need to connect with customers anytime, anywhere, so it’s logical to see them leading the charge in implementing mobile strategies,” John Reed, Senior Executive Director, Robert Half Technology said in a statement. “Compliance issues have made it difficult for the healthcare industry to move as quickly as other sectors, but as consumer demand for mobile health information grows, formal mobile strategies are a necessary next step.”
Last year, a different study was conducted to measure 100 healthcare CIOS and other health IT professionals to evaluate provider settings. The study found that 17 percent believed that mobile health would have a more significant impact on healthcare than either integrated healthcare facilities or the inclusion of EHR technology.
So, what do all these numbers mean in the short-term and long-term goals? Healthcare companies need to spend equal time investing in mobile health initiatives, and employing better means of accessibility to these heavily-invested in ideas. Without access to these create healthcare apps, how will the public benefit from them?
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”